Li Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Li Wu has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Binghong Li
Department of Medical Imaging, First Affiliated Hospital of Kunming Medical University, Kunming, China
1 shared publication- Bo He
Department of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China
1 shared publication Chenyun Wang
Medical Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences/Peking Union Medical College, Kunming, Yunnan, PR China
1 shared publicationConghui Ai
Department of Radiology, the Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming, Yunnan, China (C.A.).
1 shared publication- Conghui Ai
Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming, China
1 shared publication - Dan Han
Department of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, China
1 shared publication
Latest Publications
- 17 July 2026
- Published by Elsevier in Academic Radiology
- Vol. 33 (10) , 4479-4488
Foundation Model-empowered Multimodal Prediction of Platinum Resistance in High-grade Serous Ovarian Cancer: A Multicenter Retrospective Study
- 17 July 2026
- Published by Elsevier in Academic Radiology
- Vol. 33 (10) , 4479-4488
Foundation Model-empowered Multimodal Prediction of Platinum Resistance in High-grade Serous Ovarian Cancer: A Multicenter Retrospective Study
- Open Access
- 8 November 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 306, 119375
Long-term (>7-year) neurodevelopmental safety assessment of genetically modified (Cry1Ab/Cry2Aj and EPSPS) maize in cynomolgus monkeys: A multimodal MRI study across two generations
- 8 November 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 306, 119375
Open AccessLong-term (>7-year) neurodevelopmental safety assessment of genetically modified (Cry1Ab/Cry2Aj and EPSPS) maize in cynomolgus monkeys: A multimodal MRI study across two generations
- Open Access
- 25 July 2023
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 14, 1254775
Corrigendum: Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection
Corrigendum: Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection
- 25 July 2023
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 14, 1254775
Open AccessCorrigendum: Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection
Corrigendum: Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection
- Open Access
- 1 February 2021
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 10 (2) , 2048-2061
Clinical utility of a computed tomography-based receiver operating characteristic curve model for the diagnosis of COVID-19
Background: The outbreak of COVID-19 poses a major and urgent threat to global public health. CT findings associated with COVID-19 pneumonia from initial diagnosis until patient recovery. This study aimed to retrospectively analyze abnormal lung changes following initial computed tomography (CT) among patients with coronavirus disease 2019 (COVID-19) in Yunnan, and to evaluate the effectiveness of a chest CT-based model for the diagnosis of COVID-19. Methods: One hundred and nine patients with COVID-19 pneumonia confirmed with the positive new coronavirus nucleic acid antibody who exhibited abnormal findings on initial CT were retrospectively analyzed. Thereafter, changes in the number, distribution, shape, and density of the lesions were observed. Further, the epidemiological, clinical, and CT imaging findings (+/−) were correlated. Following univariate and multivariate logistic regression analysis, receiver operating characteristic (ROC) curves were generated for significant factors, and models were established to evaluate the diagnostic ability of CT for COVID-19. Results: Our results showed significant differences between patients with COVID-19 in epidemiological history (first, second, and third generation), clinical type (moderate, severe, and critical), and abnormal CT imaging characteristics (+/−) (PConclusions: The ROC curve regression model based on chest CT signs displayed a high diagnostic value for COVID-19.
- 1 February 2021
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 10 (2) , 2048-2061
Open AccessClinical utility of a computed tomography-based receiver operating characteristic curve model for the diagnosis of COVID-19
Background: The outbreak of COVID-19 poses a major and urgent threat to global public health. CT findings associated with COVID-19 pneumonia from initial diagnosis until patient recovery. This study aimed to retrospectively analyze abnormal lung changes following initial computed tomography (CT) among patients with coronavirus disease 2019 (COVID-19) in Yunnan, and to evaluate the effectiveness of a chest CT-based model for the diagnosis of COVID-19. Methods: One hundred and nine patients with COVID-19 pneumonia confirmed with the positive new coronavirus nucleic acid antibody who exhibited abnormal findings on initial CT were retrospectively analyzed. Thereafter, changes in the number, distribution, shape, and density of the lesions were observed. Further, the epidemiological, clinical, and CT imaging findings (+/−) were correlated. Following univariate and multivariate logistic regression analysis, receiver operating characteristic (ROC) curves were generated for significant factors, and models were established to evaluate the diagnostic ability of CT for COVID-19. Results: Our results showed significant differences between patients with COVID-19 in epidemiological history (first, second, and third generation), clinical type (moderate, severe, and critical), and abnormal CT imaging characteristics (+/−) (PConclusions: The ROC curve regression model based on chest CT signs displayed a high diagnostic value for COVID-19.
- Open Access
- 19 June 2020
- Published by PAGEPress Publications in European Journal of Histochemistry
- Vol. 64
Co-transplantation of bone marrow mesenchymal stem cells and monocytes in the brain stem to repair the facial nerve axotomy
After the facial nerve axotomy (FNA), the distal end of the axon would gradually decay and disappear. Accumulated evidence shows that transplantation of bone marrow mesenchymal stem cells (BMSCs) reveals potential in the treatment of nervous system diseases or injuries. This study is aimed at investigating the therapeutic effects of co-transplantation of BMSCs and monocytes in FNA. We found that co-culture significantly elevated the CD4+/CD8+ ratio and CD4+ CD25+ T cell proportion compared with monocytes transplantation, and enhanced the differentiation of BMSCs into neurons. After the cell transplantation, the lowest apoptosis in the facial nerve nucleus was found in the co-transplantation group 2 (BMSCs:monocytes= 1:30). Moreover, the lowest expression levels of pro-inflammatory cytokines and the highest expression levels of anti-inflammatory cytokines were observed in the co-transplantation group 2 (BMSCs: monocytes= 1:30). The highest expression levels of protein in the JAK/STAT6 pathway and the SDF-1/CXCR4 axis were found in the co-transplantation group 2. BMSC/monocyte co-transplantation significantly improves the microenvironment in the facial nerve nucleus in FNA rats; therefore these findings suggest that it could promote the anti-/pro-inflammatory balance shift towards the anti-inflammatory microenvironment, alleviating survival conditions for BMSCs, regulating BMSC the chemotaxis homing, differentiation, and the section of BMSCs, and finally reducing the neuronal apoptosis. These findings might provide essential evidence for the in-hospital treatment of FNA with co-transplantation of BMSCs and monocytes.
- 19 June 2020
- Published by PAGEPress Publications in European Journal of Histochemistry
- Vol. 64
Open AccessCo-transplantation of bone marrow mesenchymal stem cells and monocytes in the brain stem to repair the facial nerve axotomy
After the facial nerve axotomy (FNA), the distal end of the axon would gradually decay and disappear. Accumulated evidence shows that transplantation of bone marrow mesenchymal stem cells (BMSCs) reveals potential in the treatment of nervous system diseases or injuries. This study is aimed at investigating the therapeutic effects of co-transplantation of BMSCs and monocytes in FNA. We found that co-culture significantly elevated the CD4+/CD8+ ratio and CD4+ CD25+ T cell proportion compared with monocytes transplantation, and enhanced the differentiation of BMSCs into neurons. After the cell transplantation, the lowest apoptosis in the facial nerve nucleus was found in the co-transplantation group 2 (BMSCs:monocytes= 1:30). Moreover, the lowest expression levels of pro-inflammatory cytokines and the highest expression levels of anti-inflammatory cytokines were observed in the co-transplantation group 2 (BMSCs: monocytes= 1:30). The highest expression levels of protein in the JAK/STAT6 pathway and the SDF-1/CXCR4 axis were found in the co-transplantation group 2. BMSC/monocyte co-transplantation significantly improves the microenvironment in the facial nerve nucleus in FNA rats; therefore these findings suggest that it could promote the anti-/pro-inflammatory balance shift towards the anti-inflammatory microenvironment, alleviating survival conditions for BMSCs, regulating BMSC the chemotaxis homing, differentiation, and the section of BMSCs, and finally reducing the neuronal apoptosis. These findings might provide essential evidence for the in-hospital treatment of FNA with co-transplantation of BMSCs and monocytes.